[Triaminopteridine in the therapy of myasthenia gravis].
D000328:Adult; D002118:Calcium / Q000378:metabolism; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D004231:Diuresis / Q000187:drug effects; D005260:Female; D006801:Humans; D009157:Myasthenia Gravis / Q000188:drug therapy*; D009388:Neostigmine / Q000627:therapeutic use*; D011188:Potassium / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D014223:Triamterene / Q000627:therapeutic use*
D002800:Cholinesterase Inhibitors; D009388:Neostigmine; D012964:Sodium; D011188:Potassium; D002118:Calcium; D014223:Triamterene
La triaminopteridina nella terapia della myasthenia gravis.